Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study

ObjectiveUndercarboxylated osteocalcin (ucOC) is one form of osteocalcin lacking full carboxylation, which plays an important role in bone homeostasis, glucose homeostasis, and energy metabolism. Our aim is to obtain the profile of serum ucOC level according to gender and age and explore its associa...

Full description

Bibliographic Details
Main Authors:	Yang Xu, Li Shen, Lianyong Liu, Zhenlin Zhang, Weiwei Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Endocrinology
Subjects:	undercarboxylated osteocalcin bone mineral density bone turnover markers osteopenia osteoporosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.843912/full

Similar Items

Vitamin D status and its associations with bone mineral density, bone turnover markers, and parathyroid hormone in Chinese postmenopausal women with osteopenia and osteoporosis
by: Xi Chen, et al.
Published: (2024-01-01)

Evaluation of serum undercarboxylated osteocalcin in premenopausal rheumatoid arthritis patients: its correlation with disease activity and bone mineral density
by: Heba A Esaily, et al.
Published: (2016-01-01)

Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women
by: Leila C. B. Zanatta, et al.

Undercarboxylated osteocalcin correlates with insulin secretion in Japanese individuals with diabetes
by: Shogo Funakoshi, et al.
Published: (2020-08-01)

Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a
by: Hailong Wang, et al.
Published: (2021-03-01)

Bone turnover markers relations to postmenopausal osteoporosis
by: Mečevska-Jovčevska Jasmina, et al.
Published: (2009-01-01)

Osteocalcin associates with bone mineral density and VDR gene polymorphisms in type 1 and type 2 diabetes
by: Ramírez Ruiz Carla, et al.
Published: (2023-10-01)

Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
by: Mori Katsuhito, et al.
Published: (2012-12-01)

Associations of dietary vitamin K and bone markers in adult Saudi females
by: Samaher F. Alsadhan, et al.
Published: (2020-07-01)

Osteocalcin and vascular function: is there a cross-talk?
by: Alexander Tacey, et al.
Published: (2021-07-01)

Association of Vitamin K Insufficiency as Evaluated by Serum Undercarboxylated Osteocalcin With Frailty in Community-Dwelling Older Adults
by: Kotaro Azuma, et al.
Published: (2022-04-01)

Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis
by: Soo Jin Yun, et al.
Published: (2024-01-01)

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
by: Jiang Y, et al.
Published: (2014-01-01)

A meta-analysis of serum osteocalcin level in postmenopausal osteoporotic women compared to controls
by: Zhongyu Liu, et al.
Published: (2019-11-01)

Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
by: Prince Thakkar, et al.
Published: (2020-02-01)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
by: Mederle OA, et al.
Published: (2018-08-01)

Association of Bone Mineral Density and Coronary Artery Calcification in Patients with Osteopenia and Osteoporosis
by: Tzyy-Ling Chuang, et al.
Published: (2020-09-01)

Bone turnover markers: Emerging tool in the management of osteoporosis
by: Sahana Shetty, et al.
Published: (2016-01-01)

Trabecular bone score as an additional therapeutic decision tool in osteoporosis and osteopenia
by: Atiporn Therdyothin, et al.
Published: (2022-09-01)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
by: Mingwei Hu, et al.
Published: (2023-07-01)

Evaluation of effective factors in decreased bone density in patients with osteoporosis and osteopenia
by: Nasser Aghamohammadzadeh (MD), et al.
Published: (2009-08-01)

Severity of Coronary Artery Involvement Correlates with Bone Turnover
by: M Jafar Mahmoodi, et al.
Published: (2008-11-01)

Severity of Coronary Artery Involvement Correlates with Bone Turnover
by: M Jafar Mahmoodi, et al.
Published: (2008-11-01)

Severity of Coronary Artery Involvement Correlates with Bone Turnover
by: M Jafar Mahmoodi, et al.
Published: (2008-12-01)

Are Bone Turnover Markers Related with Fracture Risk in Initial Diagnose Postmenopausal Osteoporosis? A Cross-Sectional Clinical Study
by: Şeniz Akçay Yalbuzdağ, et al.
Published: (2015-08-01)

The role of osteocalcin in regulation of glycolipid metabolism and muscle function in children with osteogenesis imperfecta
by: Wen-bin Zheng, et al.
Published: (2022-08-01)

Effects of Multispecies Probiotic Supplementation on Serum Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Marut Vanitchanont, et al.
Published: (2024-02-01)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
by: Lu C, et al.
Published: (2017-10-01)

The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
by: Hüsniye Koç, et al.
Published: (2004-12-01)

Male subclinical hypogonadism and late-onset hypergonadotrophic hypogonadism: mechanisms, endothelial function, and interplay between reproductive hormones, undercarboxylated osteocalcin, and endothelial dysfunction
by: Ragaa Abedelshaheed Matta, et al.
Published: (2022-12-01)

Effect of Strength Training Protocol on Bone Mineral Density for Postmenopausal Women with Osteopenia/Osteoporosis Assessed by Dual-Energy X-ray Absorptiometry (DEXA)
by: Iulian Ștefan Holubiac, et al.
Published: (2022-02-01)

Association of Plasma Sex-Related Hormones Levels with Bone Mineral Densities and Risk of Osteoporosis and Osteopenia in Men and Menopausal Women with Type 2 Diabetes Mellitus
by: Lu W, et al.
Published: (2023-02-01)

Relationship of high circulating cystatin c to biochemical markers of bone turnover and bone mineral density in elderly males with a chronic heart failure
by: Božić-Nedeljković Biljana, et al.
Published: (2019-01-01)

Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial
by: Sakda Arj-Ong Vallibhakara, et al.
Published: (2021-11-01)

The Relationship Between the FRAX Tool and Bone Turnover Markers in Postmenopausal Osteoporosis
by: Murat Uludağ, et al.
Published: (2013-08-01)

The Association of Serum Osteocalcin with the Bone Mineral Density in Post Menopausal Women
by: Kalai Selvi VS, et al.
Published: (2013-05-01)

Effect of type of sport, weekly physical exertion and body mass index on values of bone turnover markers in elite female athletes
by: Nenad Ponorac, et al.
Published: (2018-12-01)

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
by: Ishikawa K, et al.
Published: (2016-12-01)

ASSOCIATION OF SERUM P1NP (N-TERMINAL PROPEPTIDE OF TYPE1 COLLAGEN) AND BONE MINERAL DENSITY (BMD) IN OSTEOPOROSIS
by: Afshan Iftikhar, et al.
Published: (2018-04-01)

Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women
by: Juan J. López-Gómez, et al.
Published: (2022-04-01)